CCL11 and neoplasm: CCR3 ligand may be up-regulated by tumour-related inflammation and involved in the progress of renal cell carcinoma (74), whereas the CCR3/eotaxin-1 loop could induce malignant cell growth in T-cell lymphomas (75, 76).